19 results on '"N'diaye C"'
Search Results
2. Suivi des enfants de moins de 2 ans sous traitement antirétroviral au Centre d’Excellence du CHU Gabriel TOURE (Département de pédiatrie, CHU Gabriel Touré, Bamako, Mali)
- Author
-
Sylla M, Coulibaly Y.A, N’diaye C, Koïta A, Koné N, Bagayoko K, Coulibaly H, Touré S, Dicko F, and Msf Paediatric Days
- Published
- 2017
- Full Text
- View/download PDF
3. Solitary neurofibroma originating from the posterior nasal septum: Transnasal endoscopic resection
- Author
-
Tall, A., N’diaye, C., Diom, E.-S., and Thiam, I.
- Published
- 2015
- Full Text
- View/download PDF
4. Neurofibrome solitaire à point de départ septal postérieur : exérèse par voie endoscopique endonasale
- Author
-
Tall, A., N’diaye, C., Diom, E.S., and Thiam, I.
- Published
- 2015
- Full Text
- View/download PDF
5. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ('Three I's') and HIV-Tuberculosis Service Integration in Lower Income Countries
- Author
-
Charles, M.K., Lindegren, M.L., Wester, C.W., Blevins, M., Sterling, T.R., Dung, N.T., Dusingize, J.C., Avit-Edi, D., Durier, N., Castelnuovo, B., Nakigozi, G., Cortes, C.P., Ballif, M., Fenner, L., Ajayi, S., Anastos, K., Bashi, J., Bishai, W., Boulle, A., Braitstein, P., Carriquiry, G., Carter, J.E., Cegielski, P., Chimbetete, C., Davies, M.-A., Diero, L., Duda, S., Egger, M., Eboua, T.F., Gasser, A., Geng, E., Gnokori, J.C., Hardwicke, L., Hoffmann, C., Huebner, R., Kancheya, N., Kiertiburanakul, S., Kim, P., Lameck, D., Leroy, V., Lewden, C., Mandalakas, A., Maskew, M., McKaig, R., Mofenson, L., Mpoudi-Etame, M., Okwara, B., Phiri, S., Prasitsuebsai, W., Petit, A., Prozesky, H., Reid, S.E., Renner, L., Reubenson, G., Sohn, A., Vo, Q., Walker, D., Wehbe, F., Wejse, C., Williams, C., Wood, R., Wools-Kaloustian, K., Yao, Z., Yunihastuti, E., Zhang, F.J., Zhao, H.X., Han, N., Merati, T.P., Wirawan, D.N., Yuliana, F., Ditangco, R., Uy, E., Bantique, R., Phanuphak, P., Ruxrungtham, K., Avihingsanon, A., Khongphattanayothin, M., Sungkanuparph, S., Sanmeema, N., Chaiwarith, R., Sirisanthana, T., Kotarathititum, W., Pham, T.T., Cuong, D.D., Ha, H.L., Nguyen, V.K., Bui, V.H., Nguyen, T.D., Sohn, A.H., Petersen, B., Cooper, D.A., Law, M.G., Jiamsakul, A., Boettiger, D.C., Wati, D.K., Atmikasari, L.P.P., Malino, I.Y., Nallusamy, R., Chan, K.C., Lumbiganon, P., Kosalaraksa, P., Tharnprisan, P., Udomphanit, T., Phongsamart, W., Wittawatmongkol, O., Dung, K.T.K., Lam, N.V., An, P.N., Loan, N.T., Truong, H.K., Du, T.Q., Chau, N.H., Do, C.V., Ha, M.T., Nipathakosol, P., Kariminia, A., Mutimura, E., Gitembagara, A., Tatwangire, J., Izabelle, I., Niyongabo, T., Twizere, C., Baramperanye, E., Edmonds, A., Yotebieng, M., Azinyue, I., Ayangma, L., Dickinson, D., Eley, B., Fritz, C., Garone, D., Giddy, J., MacPhail, P., Moultrie, H., Ndirangu, J., Pestilli, S., Rabie, H., Stringer, J., Technau, K., Graber, C., Kaeser, F., Keiser, O., Cornell, M., Maxwell, N., Zannou, D.M., Ahouada, C., Akakpo, J., Ahomadegbé, C., Gougounon-Houéto, A., Azon-Kouanou, A., Houngbé, F., Sehonou, J., Koumakpaï, S., Alihonou, F., D'Almeida, M., Hodonou, I., Hounhoui, G., Sagbo, G., Tossa-Bagnan, L., Adjide, H., Drabo, J., Bognounou, R., Dienderé, A., Traore, E., Zoungrana, L., Zerbo, B., Sawadogo, A.B., Zoungrana, J., Héma, A., Soré, I., Bado, G., Tapsoba, A., Yé, D., Kouéta, F., Ouedraogo, S., Ouédraogo, R., Hiembo, W., Gansonré, M., Messou, E., Gnokoro, J.C., Koné, M., Kouakou, G.M., Bosse, C.A., Brou, K., Assi, A.I., Chenal, H., Hawerlander, D., Soppi, F., Minga, A., Abo, Y., Yoboue, J.-M., Eholié, S.P., Amego, M.D.N., Andavi, V., Diallo, Z., Ello, F., Tanon, A.K., Koule, S.O., Anzan, K.C., Guehi, C., Aka, E.A., Issouf, K.L., Kouakou, J.-C., N'Gbeche, M.-S., Pety, T., Kouakou, K., Moh, M., Yao, V.A., Folquet, M.A., Dainguy, M.-E., Kouakou, C., Méa-Assande, V.T., Oka-Berete, G., Zobo, N., Acquah, P., Kokora, M.-B., Timité-Konan, M., Ahoussou, L.D., Assouan, J.K., Sami, M.F., Kouadio, C., Goka, B., Welbeck, J., Sackey, A., Owiafe, S.N., Da Silva, Z.J., Paulo, J., Rodrigues, A., Da Silva, D., Medina, C., Oliviera-Souto, I., Østergaard, L., Laursen, A., Sodemann, M., Aaby, P., Fomsgaard, A., Erikstrup, C., Eugen-Olsen, J., Maïga, M.Y., Diakité, F.F., Kalle, A., Katile, D., Traore, H.A., Minta, D., Cissé, T., Dembelé, M., Doumbia, M., Fomba, M., Kaya, A.S., Traoré, A.M., Traoré, H., Toure, A.A., Dicko, F., Sylla, M., Berthé, A., Traoré, H.C., Koïta, A., Koné, N., N'Diaye, C., Coulibaly, S.T., Traoré, M., Traoré, N., Charurat, M., Alim, G., Dapiap, S., Otu, Igbinoba, F., Benson, O., Adebamowo, C., James, J., Obaseki, Osakede, P., Olasode, J., Seydi, M., Sow, P.S., Diop, B., Manga, N.M., Tine, J.M., Bassabi, C.C., Sy, H.S., Ba, A., Diagne, A., Dior, H., Faye, M., Gueye, R.D., Mbaye, A.D., Patassi, A., Kotosso, A., Kariyare, B.G., Gbadamassi, G., Komi, A., Mensah-Zukong, K.E., Pakpame, P., Lawson-Evi, A.K., Atakouma, Y., Takassi, E., Djeha, A., Ephoévigah, A., Djibril, S.E.-H., Dabis, F., Bissagnene, E., Arrivé, E., Coffie, P., Ekouevi, D., Jaquet, A., Sasco, A.J., Amani, D., Azani, J.-C., Balestre, E., Bessekon, S., Bohossou, F., Gilbert, C., Karcher, S., Gonsan, J.M., Le Carrou, J., Lenaud, S., Nchot, C., Malateste, K., Yao, A.R., Siloué, B., Clouet, G., Dosso, M., Doring, A., Kouakou, A., Rabourdin, E., Rivenc, J., Anglaret, X., Ba, B., Essanin, J.B., Ciaranello, A., Datté, S., Desmonde, S., Diby, J.-S.E., Gottlieb, G.S., Horo, A.G., Kangah, S.N., Malvy, D., Meless, D., Mounkaila-Harouna, A., Ndondoki, C., Shiboski, C., Tchounga, B., Thiébaut, R., Wandeler, G., McGowan, C., Cahn, P., Gotuzzo Herencia, José Eduardo, Reyes, M.W., Grinsztejn, B., Pape, J.W., Padgett, D., and Madero, J.S.
- Subjects
0301 basic medicine ,Program evaluation ,Bacterial Diseases ,poverty ,Physiology ,Antitubercular Agents ,lcsh:Medicine ,HIV Infections ,Pathology and Laboratory Medicine ,Occupational safety and health ,Geographical Locations ,0302 clinical medicine ,case finding ,Health care ,lowest income group ,Medicine and Health Sciences ,Coughing ,Medicine ,Infection control ,030212 general & internal medicine ,lcsh:Science ,fever ,Multidisciplinary ,antiretrovirus agent ,adult ,HIV diagnosis and management ,sputum smear ,Vaccination and Immunization ,3. Good health ,Infectious Diseases ,Caribbean Region ,Tuberculosis Diagnosis and Management ,protective equipment ,tuberculosis control ,Research Article ,medicine.medical_specialty ,isoniazid ,Tuberculosis ,Asia ,integrated health care system ,030106 microbiology ,HIV prevention ,Immunology ,Developing country ,Antiretroviral Therapy ,complication ,610 Medicine & health ,World Health Organization ,Article ,03 medical and health sciences ,Signs and Symptoms ,Tuberculosis diagnosis ,Antiviral Therapy ,Human immunodeficiency virus infection ,night sweat ,360 Social problems & social services ,Environmental health ,parasitic diseases ,Isoniazid ,Humans ,purl.org/pe-repo/ocde/ford#3.01.05 [https] ,human ,coughing ,Poverty ,tuberculin test ,Caribbean ,Preventive medicine ,Infection Control ,AIDS-Related Opportunistic Infections ,business.industry ,screening ,lcsh:R ,Biology and Life Sciences ,occupational safety ,South America ,medicine.disease ,Tropical Diseases ,Diagnostic medicine ,mask ,Public and occupational health ,purl.org/pe-repo/ocde/ford#3.02.07 [https] ,People and Places ,Africa ,Physical therapy ,tuberculostatic agent ,lcsh:Q ,weight reduction ,business ,Physiological Processes - Abstract
SETTING World Health Organization advocates for integration of HIV-tuberculosis (TB) services and recommends intensive case finding (ICF), isoniazid preventive therapy (IPT), and infection control ("Three I's") for TB prevention and control among persons living with HIV. OBJECTIVE To assess the implementation of the "Three I's" of TB-control at HIV treatment sites in lower income countries. DESIGN Survey conducted between March-July, 2012 at 47 sites in 26 countries: 6 (13%) Asia Pacific, 7 (15%), Caribbean, Central and South America, 5 (10%) Central Africa, 8 (17%) East Africa, 14 (30%) Southern Africa, and 7 (15%) West Africa. RESULTS ICF using symptom-based screening was performed at 38% of sites; 45% of sites used symptom-screening plus additional diagnostics. IPT at enrollment or ART initiation was implemented in only 17% of sites, with 9% of sites providing IPT to tuberculin-skin-test positive patients. Infection control measures varied: 62% of sites separated smear-positive patients, and healthcare workers used masks at 57% of sites. Only 12 (26%) sites integrated HIV-TB services. Integration was not associated with implementation of TB prevention measures except for IPT provision at enrollment (42% integrated vs. 9% non-integrated; p = 0.03). CONCLUSIONS Implementation of TB screening, IPT provision, and infection control measures was low and variable across regional HIV treatment sites, regardless of integration status.
- Published
- 2016
- Full Text
- View/download PDF
6. Bandwidths limitations of giant optical field enhancements in dielectric multi-layers
- Author
-
Zerrad, M., primary, Lereu, A. L., additional, N’diaye, C., additional, Lemarchand, F., additional, and Amra, C., additional
- Published
- 2017
- Full Text
- View/download PDF
7. S-shaped non-paraxial corrections to general astigmatic beams
- Author
-
Liu, X., primary, Cassou, K., additional, Dupraz, K., additional, Favier, P., additional, Huang, W. H., additional, Martens, A., additional, N’Diaye, C. F., additional, Tang, C. X., additional, Williams, T., additional, Yan, L. X., additional, and Zomer, F., additional
- Published
- 2017
- Full Text
- View/download PDF
8. ORAL LESIONS OF HIV-INFECTED CHILDREN IN WEST AFRICA IN THE ERA OF ANTIRETROVIRAL TREATMENTS
- Author
-
Meless, D., N’Diaye, C., Nadri, J., Dicko, F., Sylla, M., Ekouévi, D.K., Dabis, F., Shiboski, C., and Arrivé, E.
- Abstract
Oral Communication presented at the "Forum des Jeunes Chercheurs", Brest (France) 2011.
- Published
- 2011
9. Myringoplastie dans le traitement des sequelles d’otite moyenne chronique non cholesteatomateuse : resultats chez 67 patients
- Author
-
Tall, A., primary, Taoussi, A., additional, Diom, E., additional, N’diaye, C., additional, Diouf, M.-S., additional, and N’diaye, I.-C., additional
- Published
- 2014
- Full Text
- View/download PDF
10. SFP P-099 - Profil et devenir des enfants mis sous ARV avant l’âge de 2 ans
- Author
-
Sylla, M., primary, Coulibaly, Y.A., additional, Diakite, A.A., additional, N’diaye, C., additional, Diallo-Koita, A., additional, and Kone, N., additional
- Published
- 2014
- Full Text
- View/download PDF
11. P338 - Suivi des nourrissons nés de mères séropositives à Bamako
- Author
-
Sylla, M., primary, Dicko- Traoré, F., additional, N’Diaye, C., additional, Traoré, Y., additional, Koné, N., additional, and Traoré, N., additional
- Published
- 2010
- Full Text
- View/download PDF
12. O-1. ORAL LESIONS OF HIV-INFECTED CHILDREN IN WEST AFRICA IN THE ERA OF ANTIRETROVIRAL TREATMENTS.
- Author
-
Meless, D., Ba, B., N'Diaye, C., Nadri, J., Dicko, F., Sylla, M., Ekouévi, D.K., Dabis, F., Shiboski, C., and Arrivé, E.
- Published
- 2011
13. [Socio-demographic, clinical, and therapeutic aspects of adolescents treated and followed for HIV infection at the Hospital Gabriel Toure paediatric center].
- Author
-
Traoré F, Coulibaly YA, Diakité AA, Maiga B, Koita A, Diall H, N'Diaye C, Maiga AI, Traoré M, Togo P, Doumbia A, Dicko-Traoré F, Togo B, and Sylla M
- Abstract
HIV infection is a chronic infectious disease requiring long-term management and regular follow-up of patients., Objectives: The aims of this study was to describe the socio-demographic, clinical, biological and therapeutic aspects of adolescents treated and followed for HIV infection at the Hospital Gabriel Toure paediatric center., Patients and Methods: From 01/01/2001 to 31/12/2017, the medical records of children followed for HIV infection until adolescence were analyzed. It was a descriptive and analytical retrospective study., Results: One thousand five hundred and fourteen patients received antiretroviral treatment and 587 were still in follow-up on 31 December 2017, including 393 adolescents (sex-ratio = 1.2). The median age was 14.25 years and 55.1% of children had lost at least one parent. HIV serology was positive among mothers in 61.7% of cases (n=342), and 63% of them were on ARVs. Sixty-eight per cent of children were WHO Stage III or IV at the time of ART initiation. The median age at onset of ART was 53 months (26-96 months). The combination of 2 nucleotide reverse transcriptase inhibitors (NRTIs) with a non-nucleotide reverse transcriptase inhibitor (NNRTI) was used in 89% of patients. The median CD4 count before ARV treatment was 438/mm3. The average duration of follow-up under treatment was 9.8 ± 3.4 years. Fifty-one percent of adolescents had undetectable viral load. There was a correlation between the initiation of a second line of treatment and treatment failure (p<0.001)., Conclusion: The adherence of adolescents to ARV treatment requires the implementation of innovative strategies to improve the therapeutic success rate., (Le comité de rédaction se réserve le droit de renvoyer aux auteurs avant toute soumission à l'avis des lecteurs les manuscrits qui ne seraient pas conformes à ces modalités de présentation. En outre il leur conseille de conserver un exemplaire du manuscrit, des figures et des tableaux.)
- Published
- 2021
14. High prevalence of dental caries among HIV-infected children in West Africa compared to uninfected siblings.
- Author
-
Rajonson N, Meless D, Ba B, Faye M, Diby JS, N'zore S, Datté S, Diecket L, N'Diaye C, Aka EA, Kouakou K, Ba A, Ekouévi DK, Dabis F, Shiboski C, and Arrivé E
- Subjects
- Adolescent, Africa, Western epidemiology, Child, Child, Preschool, Cross-Sectional Studies, DMF Index, Female, Humans, Male, Prevalence, Siblings, Dental Caries epidemiology, HIV Infections epidemiology
- Abstract
Introduction: The objectives of this study were to investigate the association between HIV infection and dental caries among children in West Africa, and to identify factors associated with dental caries among HIV-infected children., Methods: We conducted a multi-center cross-sectional study in Mali, Senegal and Côte d'Ivoire with a random sample of HIV-infected children aged 5-15 years on antiretroviral therapy and their uninfected siblings. A standardized examination was performed by calibrated dentists. The association between the number of decayed, missing or filled permanent and primary teeth surfaces (DMFdefS) and HIV status was investigated by fitting multivariable zero-inflated negative binomial models, for each age group (<12 and ≥12 years). Factors associated with dental caries could be investigated only for HIV-infected children <12 years old., Results: The sample included 420 HIV-infected children and 418 non-infected siblings. The median DMFdefS was 7 for the HIV-infected children and 2 for the uninfected siblings. The proportion of children with DMFdefS ≥1 was significantly higher among the HIV-infected children than uninfected children (86.0 percent versus 64.4 percent, P < 0.001). The HIV-infected children were less likely to be caries-free than the uninfected siblings in both age groups. We found a higher degree of caries experience among HIV-infected children < 12 years old, in whom it was associated with sweet drink consumption, history of night bottle use, immunosuppression, and younger age at study entry., Conclusions: Although preventable, the burden of dental disease was high in children from families affected by HIV in West Africa and was associated with HIV infection and immunosuppression., (© 2017 American Association of Public Health Dentistry.)
- Published
- 2017
- Full Text
- View/download PDF
15. Oral lesions among HIV-infected children on antiretroviral treatment in West Africa.
- Author
-
Meless D, Ba B, Faye M, Diby JS, N'zoré S, Datté S, Diecket L, N'Diaye C, Aka EA, Kouakou K, Ba A, Ekouévi DK, Dabis F, Shiboski C, and Arrivé E
- Subjects
- Adolescent, Africa, Western epidemiology, CD4 Lymphocyte Count, Child, Child, Preschool, Confidence Intervals, Cross-Sectional Studies, Disease Progression, Female, HIV Infections drug therapy, HIV Infections immunology, Humans, Logistic Models, Male, Mouth Diseases pathology, Mouth Diseases virology, Odds Ratio, Oral Health statistics & numerical data, Oral Hygiene statistics & numerical data, Parotid Gland pathology, Anti-Retroviral Agents therapeutic use, Dental Caries epidemiology, HIV Infections epidemiology, Mouth Diseases epidemiology
- Abstract
Objective: To estimate the prevalence of oral mucosal diseases and dental caries among HIV-infected children receiving antiretroviral treatment (ART) in West Africa and to identify the factors associated with the prevalence of oral mucosal lesions., Methods: Multicentre cross-sectional survey in five paediatric HIV clinics in Côte d'Ivoire, Mali and Sénégal. A standardised examination was performed by trained dentists on a random sample of HIV-infected children aged 5-15 years receiving ART. The prevalence of oral and dental lesions and mean number of decayed, missing/extracted and filled teeth (DMFdefT) in temporary and permanent dentition were estimated with their 95% confidence interval (95% CI). We used logistic regression to explore the association between children's characteristics and the prevalence of oral mucosal lesions, expressed as prevalence odds ratio (POR)., Results: The median age of the 420 children (47% females) enrolled was 10.4 years [interquartile range (IQR) = 8.3-12.6]. The median duration on ART was 4.6 years (IQR = 2.6-6.2); 84 (20.0%) had CD4 count<350 cells/mm(3). A total of 35 children (8.3%; 95% CI: 6.1-11.1) exhibited 42 oral mucosal lesions (24 were candidiasis); 86.0% (95% CI = 82.6-89.3) of children had DMFdefT ≥ 1. The presence of oral mucosal lesions was independently associated with CD4 count < 350 cells/mm(3) (POR = 2.96, 95% CI = 1.06-4.36) and poor oral hygiene (POR = 2.69, 95% CI = 1.07-6.76)., Conclusions: Oral mucosal lesions still occur in HIV-infected African children despite ART, but rarely. However, dental caries were common and severe in this population, reflecting the need to include oral health in the comprehensive care of HIV., (© 2014 John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
16. Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.
- Author
-
Ekouevi DK, Balestre E, Coffie PA, Minta D, Messou E, Sawadogo A, Minga A, Sow PS, Bissagnene E, Eholie SP, Gottlieb GS, Dabis F, Zannou DM, Ahouada C, Akakpo J, Ahomadegbé C, Bashi J, Gougounon-Houéto A, Azon-Kouanou A, Houngbé F, Koumakpaï S, Alihonou F, d'Almeida M, Hodonou I, Hounhoui G, Sagbo G, Tossa-Bagnan L, Adjide H, Drabo J, Bognounou R, Dienderé A, Traore E, Zoungrana L, Zerbo B, Sawadogo AB, Zoungrana J, Héma A, Soré I, Bado G, Tapsoba A, Yé D, Kouéta F, Ouedraogo S, Ouédraogo R, Hiembo W, Gansonré M, Messou E, Gnokoro JC, Koné M, Kouakou GM, Bosse CA, Brou K, Assi AI, Chenal H, Hawerlander D, Soppi F, Minga A, Abo Y, Bomisso G, Eholié SP, Amego MD, Andavi V, Diallo Z, Ello F, Tanon AK, Koule SO, Anzan KC, Guehi C, Aka EA, Issouf KL, Kouakou JC, N'gbeche MS, Touré P, Avit-Edi D, Kouakou K, Moh M, Yao VA, Folquet MA, Dainguy ME, Kouakou C, Méa-Assande VT, Oka-Berete G, Zobo N, Acquah P, Kokora MB, Eboua TF, Timité-Konan M, Ahoussou LD, Assouan JK, Sami MF, Kouadio C, Renner L, Goka B, Welbeck J, Sackey A, Owiafe SN, Wejse C, Silva ZJ, Paulo J, Rodrigues A, da Silva D, Medina C, Oliviera-Souto I, Ostergaard L, Laursen A, Sodemann M, Aaby P, Fomsgaard A, Erikstrup C, Eugen-Olsen J, Maïga MY, Diakité FF, Kalle A, Katile D, Traore HA, Minta D, Cissé T, Dembelé M, Doumbia M, Fomba M, Kaya AS, Traoré AM, Traoré H, Toure AA, Dicko F, Sylla M, Berthé A, Traoré HC, Koïta A, Koné N, N'diaye C, Coulibaly ST, Traoré M, Traoré N, Charurat M, Ajayi S, Dapiap S, Otu, Igbinoba F, Benson O, Adebamowo C, James J, Obaseki, Osakede P, Olasode J, Sow PS, Diop B, Manga NM, Tine JM, Signate Sy H, Ba A, Diagne A, Dior H, Faye M, Gueye RD, Mbaye AD, Patassi A, Kotosso A, Kariyare BG, Gbadamassi G, Komi A, Mensah-Zukong KE, Pakpame P, Lawson-Evi AK, Atakouma Y, Takassi E, Djeha A, Ephoévi-Gah A, Djibril Sel-H, Dabis F, Bissagnene E, Arrivé E, Coffie P, Ekouevi D, Jaquet A, Leroy V, Lewden C, Sasco A, Azani JC, Allou G, Balestre E, Bohossou F, Karcher S, Gonsan JM, Carrou JL, Lenaud S, Nchot C, Malateste K, Yao AR, Siloué B, Clouet G, Djetouan H, Doring A, Kouakou A, Rabourdin E, Rivenc J, Anglaret X, Ba B, Essanin JB, Ciaranello A, Datté S, Desmonde S, Diby JS, Gottlieb GS, Horo AG, Kangah SN, Malvy D, Meless D, Mounkaila-Harouna A, Ndondoki C, Shiboski C, Thiébaut R, Pac-Ci, and Abidjan
- Subjects
- Adult, Africa, Western epidemiology, Cohort Studies, Female, HIV Infections virology, Humans, Male, Middle Aged, Anti-HIV Agents therapeutic use, HIV Infections drug therapy, HIV-1 isolation & purification, HIV-2 isolation & purification
- Abstract
Background: HIV-2 is endemic in West Africa. There is a lack of evidence-based guidelines on the diagnosis, management and antiretroviral therapy (ART) for HIV-2 or HIV-1/HIV-2 dual infections. Because of these issues, we designed a West African collaborative cohort for HIV-2 infection within the framework of the International epidemiological Databases to Evaluate AIDS (IeDEA)., Methods: We collected data on all HIV-2 and HIV-1/HIV-2 dually seropositive patients (both ARV-naive and starting ART) and followed-up in clinical centres in the IeDEA-WA network including a total of 13 clinics in five countries: Benin, Burkina-Faso Côte d'Ivoire, Mali, and Senegal, in the West Africa region., Results: Data was merged for 1,754 patients (56% female), including 1,021 HIV-2 infected patients (551 on ART) and 733 dually seropositive for both HIV-1 and HIV 2 (463 on ART). At ART initiation, the median age of HIV-2 patients was 45.3 years, IQR: (38.3-51.7) and 42.4 years, IQR (37.0-47.3) for dually seropositive patients (p = 0.048). Overall, 16.7% of HIV-2 patients on ART had an advanced clinical stage (WHO IV or CDC-C). The median CD4 count at the ART initiation is 166 cells/mm(3), IQR (83-247) among HIV-2 infected patients and 146 cells/mm(3), IQR (55-249) among dually seropositive patients. Overall, in ART-treated patients, the CD4 count increased 126 cells/mm(3) after 24 months on ART for HIV-2 patients and 169 cells/mm(3) for dually seropositive patients. Of 551 HIV-2 patients on ART, 5.8% died and 10.2% were lost to follow-up during the median time on ART of 2.4 years, IQR (0.7-4.3)., Conclusions: This large multi-country study of HIV-2 and HIV-1/HIV-2 dual infection in West Africa suggests that routine clinical care is less than optimal and that management and treatment of HIV-2 could be further informed by ongoing studies and randomized clinical trials in this population.
- Published
- 2013
- Full Text
- View/download PDF
17. Oral lesions of HIV-infected children in West Africa in the era of antiretroviral treatments.
- Author
-
Meless D, Ba B, N'Diaye C, Nadri J, Dicko F, Sylla M, Ekouévi DK, Dabis F, Shiboski C, and Arrivé E
- Subjects
- Africa, Western, Child, Humans, Mouth Diseases, Antiretroviral Therapy, Highly Active, HIV Infections
- Published
- 2011
18. [Essential indicators of orodental health in Africa. Applicability in Ivory Coast].
- Author
-
Yavo Tchere ML, N'Diaye C, and Bourgeois D
- Subjects
- Adolescent, Child, Cote d'Ivoire, Databases as Topic, Health Education, Dental, Health Promotion, Health Services Accessibility, Humans, Population Surveillance, Primary Prevention, Reproducibility of Results, Risk Factors, Toothbrushing, Health Status Indicators, Oral Health
- Abstract
INTEREST OF THE PROBLEM: The objective of this study is to highlight the gaps from a consideration of the essential indicators in the national system of sanitary information of Ivory Coast. Modalities of their applicability in the surveillance of the oral health are also discussed., Position of the Problem: The use of the essential indicators answers the necessity of setting up a system of surveillance of the common factors of risk based on standardized information which will allow comparisons between countries. However, the applicability of these indicators is not enough known and the quantitative measure to test their reliability and their validity was not realized yet to allow their easy consideration in global Infobase., Method: This study is based on the documentary analysis of the catalogue on selection of the essential indicators, and the database of the national program of oral health., Results: Twenty-two essential indicators are applicable in the national information system. In particular, ten indicators are easily applicable without technical difficulties and twelve are averagely applicable., Conclusion: The essential indicators are pertinent for the surveillance of the oral health in Côte d'Ivoire. However, future researches are necessary to test their validity in the national information system. Also, similar pilot studies could be realized in the other African contexts to establish an operational and standardized frame to collect relevant and valid information.
- Published
- 2009
19. Synthesis and antimalarial activity in vitro of potential metabolites of ferrochloroquine and related compounds.
- Author
-
Biot C, Delhaes L, N'Diaye CM, Maciejewski LA, Camus D, Dive D, and Brocard JS
- Subjects
- Animals, Antimalarials chemistry, Chloroquine chemical synthesis, Chloroquine pharmacology, Drug Evaluation, Preclinical, Drug Resistance, Humans, In Vitro Techniques, Magnetic Resonance Spectroscopy, Malaria, Falciparum drug therapy, Plasmodium falciparum drug effects, Structure-Activity Relationship, Antimalarials chemical synthesis, Antimalarials pharmacology, Chloroquine analogs & derivatives
- Abstract
In man, the two major metabolites of the antimalarial drug chloroquine (CQ) are monodesethylchloroquine (DECQ) and didesethylchloroquine (di-DECQ). By analogy with CQ, the synthesis and the in vitro tests of some amino derivatives of ferrochloroquine (FQ), a ferrocenic analogue of CQ which are presumed to be the oxidative metabolites of FQ, are reported. Desmethylferrochloroquine 1a and didesmethylferrochloroquine 2 would be more potent against schizontocides than CQ in vitro against two strains (HB3 and Dd2) of Plasmodium falciparum. Other secondary amino derivatives have been prepared and proved to be active as antimalarial agents in vitro, too.
- Published
- 1999
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.